| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/26/2011 | WO2011062766A2 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| 05/26/2011 | WO2011062437A2 Gonadotropin releasing hormone receptor antagonists, manufacturing method thereof, and pharmaceutical composition containing same |
| 05/26/2011 | WO2011061996A1 Process for production of biphenyl derivative |
| 05/26/2011 | WO2011061613A1 Process for the preparation of crystalline form ii of l-malic acid salt of sunitinib |
| 05/26/2011 | WO2011061139A1 Substituted pyrrolidine-2-carboxamides |
| 05/26/2011 | WO2011060873A1 Quinazoline derivatives |
| 05/26/2011 | WO2011060859A1 Materials for organic electroluminescent devices |
| 05/26/2011 | WO2011060746A1 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use |
| 05/26/2011 | WO2011042797A4 Pyrazole derivatives as modulators of calcium release -activated calcium channel |
| 05/26/2011 | WO2011033472A4 Salts of sunitinib |
| 05/26/2011 | WO2011023680A3 Processes for the synthesis and purification of heterobifunctional cross-linkers |
| 05/26/2011 | WO2011005052A3 Novel arylpiperazine-containing imidazole 4-carboxamide derivatives and pharmaceutical composition comprising same |
| 05/26/2011 | WO2011005029A3 Method for preparing 5-chloro-n-({(5s)-2-oxo-3-[4-(5,6-dihydro-4h-[1,2,4]triazin-1-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophen-2-carboxamide derivative and intermediate used therein |
| 05/26/2011 | WO2011002520A3 Small molecule inhibitors of parp activity |
| 05/26/2011 | WO2010138720A3 Compounds and methods for chelating metals in aqueous solutions |
| 05/26/2011 | US20110124867 Process and intermediates for the Synthesis of heterocyclic Substituted Piperazines with CXCR3 Antagonist Activity |
| 05/26/2011 | US20110124673 6-alkenyl and 6-phenylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 05/26/2011 | US20110124669 Modulators of Cellular Adhesion |
| 05/26/2011 | US20110124668 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 05/26/2011 | US20110124664 Polycationic Compounds And Uses Thereof |
| 05/26/2011 | US20110124663 Substituted dioxopiperidines and dioxopyrrolidines as mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 05/26/2011 | US20110124660 Novel Diazinylpyrazolyl Compounds |
| 05/26/2011 | US20110124657 Method for screening of 5ht7 receptor ligands based on a new pharmacophore model and a descriptor's profile filter |
| 05/26/2011 | US20110124654 Diazacarbazoles and methods of use |
| 05/26/2011 | US20110124643 Pyridinopyridinone derivatives, preparation thereof and therapeutic use thereof |
| 05/26/2011 | US20110124637 Benzimidazoles and related analogs as sirtuin modulators |
| 05/26/2011 | US20110124628 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 05/26/2011 | US20110124626 Benzazepine derivatives and their use as histamine h3 antagonists |
| 05/26/2011 | US20110124625 Modulators of Cellular Adhesion |
| 05/26/2011 | US20110124619 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators |
| 05/26/2011 | US20110124618 Substituted (pyrazolylcarbonyl)imidazolidinones and their use |
| 05/26/2011 | US20110124585 Dimeric Small Molecule Potentiators of Apoptosis |
| 05/26/2011 | US20110124573 Osmoprotective Complexes for Prevention of Intra-cellular Dehydration in Mammals |
| 05/26/2011 | US20110123450 Macrocyclic cyanine and indocyanine bioconjugates provide improved biomedical application |
| 05/26/2011 | US20110121721 Light-Emitting Element, Light-Emitting Device, Electronic Device and Quinoxaline Derivative |
| 05/26/2011 | US20110121275 Anthracene Derivative, and Light Emitting Element, Light Emitting Device, and Electronic Device Using the Anthracene Derivative |
| 05/26/2011 | CA2781380A1 Quinazoline derivatives |
| 05/26/2011 | CA2781066A1 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use |
| 05/26/2011 | CA2780287A1 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties |
| 05/26/2011 | CA2778867A1 Substituted pyrrolidine-2-carboxamides |
| 05/25/2011 | EP2325263A1 Modified carbocyanine dyes and their conjugates |
| 05/25/2011 | EP2325180A1 Chiral CIS-imidazolines |
| 05/25/2011 | EP2325175A1 2,4-diaminopyrimidine compound |
| 05/25/2011 | EP2325174A1 Sigma receptor inhibitors |
| 05/25/2011 | EP2324830A1 Process for the preparation of a monocyclic azole derivative that inhibits the interaction of ligands with rage |
| 05/25/2011 | EP2324013A1 Substituted-quinoxaline-type bridged-piperidine compounds and the uses thereof |
| 05/25/2011 | EP2324012A1 New compounds |
| 05/25/2011 | EP2324008A1 3,4-diarylpyrazoles as protein kinase inhibitors |
| 05/25/2011 | EP2323993A2 2,6-diamino- pyrimidin- 5-yl-carboxamides as syk or jak kinases inhibitors |
| 05/25/2011 | EP2323992A1 5-alkynyl-pyrimidines |
| 05/25/2011 | EP2323991A2 Chymase inhibitors |
| 05/25/2011 | EP2323987A1 N-myristoyl transferase inhibitors |
| 05/25/2011 | EP2323986A2 Hetoerocyclyl carbonic acid amides as antiproliferative agents, pdkl inhibitors |
| 05/25/2011 | EP2323980A1 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases |
| 05/25/2011 | EP2323737A2 Triazole compounds that modulate hsp90 activity |
| 05/25/2011 | EP2212297B1 Inhibitors of protein kinases |
| 05/25/2011 | EP2125748B1 Acylaminopyrazoles as fgfr inhibitors |
| 05/25/2011 | EP2021335B1 Heterocyclic compounds as inhibitors of c-fms kinase |
| 05/25/2011 | EP1868994B1 Sulfonylpyrroles as histone deacetylase inhibitors |
| 05/25/2011 | CN1980674B Phthalazine derivatives as parp inhibitors |
| 05/25/2011 | CN1863770B Cyclic amine BASE-1 inhibitors having a heterocyclic substituent |
| 05/25/2011 | CN1832938B N-heterocyclyl phenyl-substituted cyclic ketoenols |
| 05/25/2011 | CN1578663B Inhibitors of histone deacetylase |
| 05/25/2011 | CN102076680A Benzoimidazoles as prolyl hydroxylase inhibitors |
| 05/25/2011 | CN102076671A Triazole derivative or salt thereof |
| 05/25/2011 | CN102070619A Triazine derivative and preparation method and application thereof in plant antibacterial agent |
| 05/25/2011 | CN102070618A Compound and crystals thereof |
| 05/25/2011 | CN102070617A Candesartan cilexetil compound and novel preparation method thereof |
| 05/25/2011 | CN102070616A Novel method for preparing voriconazole crystal formation B |
| 05/25/2011 | CN102070615A Nitroxyl radical anti-tumor medicaments |
| 05/25/2011 | CN101475526B Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 05/25/2011 | CN101374808B Indole sulfonamide modulators of progesterone receptors |
| 05/25/2011 | CN101027286B Indozolone derivatives as 11b-HSD1 inhibitors |
| 05/24/2011 | US7947839 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use |
| 05/24/2011 | US7947835 Certain substituted amides, method of making, and method of use thereof |
| 05/24/2011 | US7947832 Water compatible sterically hindered alkoxyamines and hydroxy substituted alkoxyamines |
| 05/24/2011 | US7947830 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
| 05/24/2011 | US7947726 Non-steroidal ligands for the glucocorticoid receptor, and compositions thereof |
| 05/24/2011 | US7947713 Tripeptidyl peptidase inhibitors |
| 05/24/2011 | US7947711 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 05/24/2011 | US7947707 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same |
| 05/24/2011 | US7947705 7-azaindoles and the use thereof as therapeutic agents |
| 05/24/2011 | US7947700 Carboxylic acid amides, the preparation thereof and their use as medicaments |
| 05/24/2011 | US7947687 Antineoplastic and curcumin derivatives and methods of preparation and use |
| 05/24/2011 | US7947683 3-(1,2,4-triazol-3-ylalkyl) azabicyclo (3.1.0) hexane derivatives as modulators of dopamine D3 receptors |
| 05/24/2011 | US7947680 Adamantyl diamide derivatives and uses of same |
| 05/24/2011 | US7947677 Spirolactam tricyclic CGRP receptor antagonists |
| 05/24/2011 | CA2490888C Diaminopyrimidinecarboxamide derivative |
| 05/24/2011 | CA2443952C Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors |
| 05/24/2011 | CA2303428C .alpha.-ketoamide multicatalytic protease inhibitors |
| 05/19/2011 | WO2011060000A1 Hepatitis c virus inhibitors |
| 05/19/2011 | WO2011059887A1 Hepatitis c virus inhibitors |
| 05/19/2011 | WO2011059463A1 Deuterated compounds for electronic applications |
| 05/19/2011 | WO2011059048A1 Novel amide derivative |
| 05/19/2011 | WO2011058524A2 Crystalline forms of bosentan salt and processes for their preparation |
| 05/19/2011 | WO2011058521A2 Process for the preparation of crystalline form i of l-malic acid salt of sunitinib |
| 05/19/2011 | WO2011058193A1 [1,5]-diazocin derivatives |
| 05/19/2011 | WO2011058179A1 5- (4- (n- (2, 3 -dimethyl- 2h- indazol- 6 -yl) -n-methylamino) pyrimidin- 2 -ylamino) -2 -methylbenzenesulfonamide |
| 05/19/2011 | WO2011058154A1 Biphenyl carboxylic acids and bioisosteres as glycogen synthase activators |
| 05/19/2011 | WO2011058139A1 A compound, a process for its preparation, a pharmaceutical composition, use of a compound, a method for modulating or regulating serine/threonine kinases and a serine/threonine kinases modulating agent |